Abstract

It is important to understand Chemotherapy induced neuropathy from two points of view. From the patient’s point of view, and from the point of view of a provider. In both perspectives, it is important to articulate the common CIPN presentations, as well as describe their clinical significance, and recognize the diagnostic conundrums, which arise whenever new neuropathies arise in cancer patients. Such knowledge helps to directly CIPN guidelines into patient care. Noting that CIPN occurs in patients, going forward, it is more important to determine why we ought to care about chemotherapy induced neuropathy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call